Market Overview

Diopsys' VEP Vision Test Saves Baby's Life


6-month-old Nora Turner failed her Enfant VEP vision test at her pediatric well-visit and was later diagnosed with retinoblastoma (cancer of the retina). Sarah Turner, Nora's mother, is grateful her daughter's cancer was found so early, but she was also upset that such a simple vision test is not available to all children. Diopsys is introducing new efforts to help Sarah share Nora's Story.

Pine Brook, NJ (PRWEB) October 25, 2012

Nora Turner had her vision, and ultimately her life, saved by a simple, but unique vision test given by her pediatrician during her six-month well visit. If Nora's family had not moved from Minnesota to Connecticut this past year, she wouldn't have had this vision test. That is because her doctors in Minnesota did not have a Visual Evoked Potential (VEP) vision testing device. This VEP vision test led to the early detection of her cancer, called Retinoblastoma, a rare form of eye cancer that is difficult to detect and appears in very young children. Without the early detection afforded from taking the VEP vision test as early as six months old, the outcome may have been very different for Nora and the Turner family.

The test given to Nora, known as the Enfant® Pediatric VEP Vision Test by Diopsys, Inc., may objectively detect vision problems earlier than traditional vision tests because it evaluates the child's entire vision system (from the eye to the brain) without the need for the patient to respond. The test utilizes a flat panel screen that features fun, child-friendly characters and graphics accompanied by music. The company also provides the Diopsys® NOVA-VEP Vision Testing System to optometrists and ophthalmologists to test vision in both children and adults.

The Diopsys VEP vision testing systems are currently available in just over 500 pediatric offices and 350 eye care professional offices nationwide. Recently Nora's mother, Sarah, started working to bring awareness to her daughter's story in the hope that it may help make this test more readily available for other children throughout the country to save their sight and maybe their lives.

The updated VEP for Kids to See Facebook page is dedicated to sharing Nora's story to help bring awareness to the role of early detection and intervention to save children's vision, and, in some cases like Nora's, to save children's lives. People around the country are now sharing Nora's Story, liking the VEP for Kids to See Facebook page and signing the petition to help support more access to VEP vision testing for kids.

About Diopsys
Diopsys, Inc. ( is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care solutions. The company specializes in the development and marketing of patient-friendly, non-invasive vision testing equipment utilizing Visual Evoked Potential (VEP) technology.

Diopsys has developed and markets the patented Diopsys® NOVA-VEP Vision Testing Systems utilized by optometrists and ophthalmologists to help in the detection, diagnosis and treatment of vision disorders, including glaucoma. Diopsys also provides the Enfant® Pediatric VEP Vision Testing System, a device used in testing for visual deficits, including amblyopia, in children as young as six months of age.

For the original version on PRWeb visit:

View Comments and Join the Discussion!